CYP2C19Your two copies: *1/*2
Intermediate metabolizer
One copy works and one doesn't.
Handles several SSRIs, acid reducers such as omeprazole, and the blood thinner clopidogrel.
This result doesn't change the label.
Example report. Made from Leslie Knope's DNA data so you can see what yours will look like. Get your own report
ImmunosuppressantsExample report
Abrocitinib
Cibinqo
Use as directed
Your body may process this drug a little more slowly. The drug label has no special advice for this, so the usual dose is used.
The genes behind this label
The guidelines read one gene for abrocitinib. Each card shows the two copies this person inherited and what they mean.
What the guidelines say
What each guideline says about your result.
CYP2C19Intermediate metabolizer
FDA drug label
Evidence: moderateSee the FDA table (U.S. Food and Drug Administration, opens in a new tab)
- In plain words
- Your body may process this drug a little more slowly. The drug label has no special advice for this, so the usual dose is used.
- What it means
- No FDA guidance for this phenotype
- What the label suggests
- Abrocitinib - label recommended dosage and administration
About abrocitinib
Abrocitinib (Cibinqo) is a once-daily tablet for moderate to severe atopic dermatitis (eczema).
- Used for
- Refractory moderate to severe atopic dermatitis in adults and children 12 and older
Others in immunosuppressants
Compare all 4 immunosuppressantsDon't change a dose on your own. Bring this report to your prescriber or pharmacist. They can weigh it with everything else they know about you.